LUCENTIS® (ranibizumab) a Treatment Option for wAMD, DR & DME, mCNV, & RVO
Learn about LUCENTIS (ranibizumab injection), a treatment option for wet AMD, diabetic macular edema (DME), diabetic retinopathy (DR), mCNV, & RVO. See full safety for more information.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
Month | Traffic |
---|---|
2025-02 | 2.671 |
2025-03 | 5.578 |
2025-04 | 5.713 |
2025-05 | 3.885 |
Source | Traffic Share |
---|---|
direct | 43.75% |
search | 33.40% |
social | 16.27% |
referrals | 5.60% |
paid referrals | 0.92% |
0.05% |
Region | Percentage |
---|---|
United States | 90.07% |
Canada | 9.93% |
No top keyword data found